LOSARTAN

Course overview

LOSARTAN IS FDA APPROVED FOR THE TREATMENT OF SEVERAL MEDICAL CONDITIONS, WHICH INCLUDE THE FOLLOWING: HYPERTENSION, DIABETIC NEPHROPATHY. ARBS ARE KNOWN TO BE RENOPROTECTIVE IN TYPE 2 DIABETES MELLITUS. IN HYPERTENSION WITH LEFT VENTRICULAR HYPERTROPHY, LOSARTAN INHIBITS ANGIOTENSIN II-INDUCED CARDIAC REMODELING. IT REDUCES THE RISK OF STROKE IN THESE PATIENTS. THIS ACTIVITY COVERS LOSARTAN, INCLUDING MECHANISM OF ACTION, PHARMACOLOGY, ADVERSE EVENT PROFILES, ELIGIBLE PATIENT POPULATIONS, MONITORING, AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF HYPERTENSION WITH LOSARTAN.